Published in Antimicrob Agents Chemother on November 01, 1991
Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureus. Antimicrob Agents Chemother (1998) 1.13
A graphic method for the determination and presentation of binding parameters in a complex system. Anal Biochem (1967) 4.32
Pharmacokinetics of ceftriaxone in humans. Antimicrob Agents Chemother (1981) 3.59
Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics. Clin Pharmacol Ther (1981) 2.93
Clinical uses of intravenous immunoglobulins. Ann Intern Med (1990) 2.29
Clinical pharmacokinetics of the third generation cephalosporins. Clin Pharmacokinet (1985) 1.70
Ceftriaxone: renal and biliary excretion and effect on the colon microflora. J Antimicrob Chemother (1982) 1.65
Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life. Chemotherapy (1981) 1.59
Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. Ann Intern Med (1987) 1.48
Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose. Eur J Clin Pharmacol (1982) 1.27
Ultrafiltration is theoretically equivalent to equilibrium dialysis but much simpler to carry out. Arch Biochem Biophys (1978) 1.13
Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency diseases. Am J Med (1984) 1.10
Ultrafiltration in serum protein binding determinations. J Pharm Sci (1981) 1.07
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerations. Eur J Clin Pharmacol (1983) 1.05
A statistical method for the estimation of binding parameters in a complex system. Anal Biochem (1976) 1.03
Intravenous immune globulin therapy in hypogammaglobulinemia. A review. Am J Med (1984) 1.03
Single-dose ceftriaxone kinetics in liver insufficiency. Clin Pharmacol Ther (1984) 0.91
High-dose intravenous immune globulin impairs antibacterial activity of antibiotics. J Allergy Clin Immunol (1989) 0.90
Protein binding of vancomycin in a patient with immunoglobulin A myeloma. Antimicrob Agents Chemother (1990) 0.89
Single-dose ceftriaxone kinetics in the newborn. Clin Pharmacol Ther (1985) 0.87
Graphical procedures for the detection of deviations from the classical model of enzyme kinetics. J Biol Chem (1974) 0.85
A calculator for finding binding parameters from a Scatchard plot. Anal Biochem (1973) 0.83
Clinical relevance of different electrophoretic methods for the analysis of urinary proteins. Curr Probl Clin Biochem (1979) 0.82
Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significance. Eur J Clin Pharmacol (1983) 0.79
Factors affecting ceftriaxone plasma protein binding during open heart surgery. J Pharm Sci (1989) 0.78
Estimation of drug binding parameters. J Pharmacokinet Biopharm (1986) 0.78
Activity of minocycline against Acinetobacter calcoaceticus var. anitratus (syn. Herellea vaginicola) and Serratia marcescens. Antimicrob Agents Chemother (1975) 2.92
Impaired neutrophil chemotaxis in patients with juvenile and rapidly progressing periodontitis. J Periodontal Res (1979) 1.70
Leukotactic dystunction in sarcoidosis. Ann Intern Med (1976) 1.50
Interpreting tuberculosis skin tests. Lancet (1996) 1.39
Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats. Peptides (1991) 1.37
Micropore filter assay of human granulocyte locomotion: problems and solutions. Clin Immunol Immunopathol (1978) 1.36
Serum-associated inhibition of leukotaxis in humans with cancer. Clin Immunol Immunopathol (1978) 1.35
Chloramphenicol: A review of its use in clinical practice. Rev Infect Dis (1981) 1.27
Flavobacterium meningosepticum meningitis in a newborn infant. Treatment with intraventricular erythromycin. J Pediatr (1974) 1.22
Aminoglycoside antibiotics moderately impair granulocyte function. Antimicrob Agents Chemother (1978) 1.20
Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis. Infect Immun (1993) 1.11
Host defense during pregnancy: neutrophil chemotaxis and adherence. Am J Obstet Gynecol (1987) 1.07
Polymorphonuclear leukocyte adherence and chemotaxis in stressed and healthy neonates. Pediatr Res (1986) 1.07
Treatment of nocardial infection with trimethoprim and sulfamethoxazole. Am J Med (1974) 1.00
Polymorphonuclear leukocyte migration abnormalities and their significance in seriously traumatized patients. Ann Surg (1983) 1.00
An evaluation of the impact of gender and age on QT dispersion in healthy subjects. Ann Noninvasive Electrocardiol (2001) 1.00
Pharmacokinetic data and drug monitoring: I. Antibiotics and antiarrhythmics. J Clin Pharmacol (1975) 1.00
Pharmacokinetics and penetration characteristics of cefazolin into human spinal fluid. Curr Ther Res Clin Exp (1976) 0.99
Pentoxifylline enhancement of defective neutrophil function and host defense in neonatal mice. Am J Pathol (1987) 0.97
Delivery of omeprazole and lansoprazole granules through a nasogastric tube in vitro. Am J Health Syst Pharm (1999) 0.97
Abnormalities of neutrophil adherence in newborns. Pediatrics (1982) 0.92
Serum protein-binding characteristics of vancomycin. Antimicrob Agents Chemother (1993) 0.91
In vivo inactivation of tobramycin by ticarcillin. A case report. JAMA (1982) 0.91
Leukocytic function in malakoplakia. Arch Pathol Lab Med (1978) 0.90
Modulation of neonatal neutrophil function by pentoxifylline. Pediatr Res (1991) 0.90
Treatment of malakoplakia with trimethoprim-sulfamethoxazole. Urology (1979) 0.89
Inhibition of human polymorphonuclear leukocyte cell responses by ibuprofen. J Pharm Sci (1984) 0.89
Indomethacin-associated sepsis in very-low-birth-weight infants. Am J Dis Child (1988) 0.87
Protective effects of ibuprofen and methylprednisolone on chemotactic factor-induced transcutaneous hypoxia. J Pharmacol Exp Ther (1986) 0.87
Once-daily aminoglycoside dosing: impact on requests and costs for therapeutic drug monitoring. Ther Drug Monit (1996) 0.86
Efficacy of intravenous granisetron in suppressing the bradycardia and hypotension associated with a rabbit model of the Bezold-Jarisch reflex. J Clin Pharmacol (1998) 0.85
Conformational and structural considerations in oxytocin-receptor binding and biological activity. Annu Rev Pharmacol Toxicol (1990) 0.85
Leukokinesis-enhancing factor in human serum: partial characterization and relationship to disorders of leukocyte migration. Clin Immunol Immunopathol (1979) 0.85
Aortic reconstruction in kidney transplant recipients. Ann Vasc Surg (1996) 0.84
Effects of amiodarone and its active metabolite desethylamiodarone on the ventricular defibrillation threshold. J Am Coll Cardiol (1998) 0.83
Cell-directed inhibitor of human leukocyte locomotion. Identification of immunoglobulin G as a cell-directed inhibitor in normal human serum. J Lab Clin Med (1981) 0.82
Aspirin. J Am Pharm Assoc (1977) 0.82
Hematologic and chemical changes observed during and after cardiac arrest in a canine model--a pilot study. Pharmacotherapy (2001) 0.82
A comparison of the antifibrillatory effects of desethylamiodarone to amiodarone in a swine model. J Cardiovasc Pharmacol (1999) 0.82
Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model. Pharmacotherapy (1999) 0.82
Treatment of the periodontal component of Papillon-Lefèvre syndrome. J Clin Periodontol (1986) 0.81
Inappropriate activation, deactivation, and probable autooxidative damage as a mechanism of neutrophil locomotory defect in trauma. J Infect Dis (1986) 0.81
Usefulness of intravenous granisetron for prevention of neurally mediated hypotension upon head upright tilt testing. Am J Cardiol (2000) 0.81
Cost savings from having a clinical pharmacist work part-time in a medical intensive care unit. Am J Health Syst Pharm (1997) 0.81
Dental treatment of Papillon-Lefèvre syndrome: 15-year follow-up. J Clin Periodontol (1995) 0.80
A comparison of 10% pentastarch and 5% albumin in patients undergoing open-heart surgery. J Clin Pharmacol (1994) 0.80
Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br J Obstet Gynaecol (1998) 0.80
Safety and efficacy of antiestrogens for prevention of breast cancer. Am J Health Syst Pharm (2000) 0.80
The effect of lidocaine and bretylium on the defibrillation threshold during cardiac arrest and cardiopulmonary resuscitation. Proc Soc Exp Biol Med (1986) 0.80
Pharmacokinetics of acetaminophen in Hong Kong Chinese subjects. Int J Pharm (2001) 0.79
Differences in systemic and myocardial blood acid-base status during cardiopulmonary resuscitation. Crit Care Med (1989) 0.79
The role of cellular maturation in neutrophil heterogeneity. Blood (1990) 0.79
Rimantadine pharmacokinetics in healthy subjects and patients with end-stage renal failure. Clin Pharmacol Ther (1988) 0.79
Mexiletine in the treatment of recurrent ventricular tachycardia. Prediction of long-term arrhythmia suppression from acute and short-term response. J Clin Pharmacol (1983) 0.79
Neutrophil heterogeneity in patients with blunt trauma. J Lab Clin Med (1988) 0.78
Two-point method for determination of aminoglycoside pharmacokinetics: theoretical and practical considerations. Ther Drug Monit (1986) 0.78
The pharmacokinetics of intravenous testosterone in elderly men with coronary artery disease. J Clin Pharmacol (1998) 0.78
Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia. Pacing Clin Electrophysiol (1997) 0.78
Local delivery of heparin to balloon angioplasty sites with a new angiotherapy catheter: pharmacokinetics and effect on platelet deposition in the porcine model. Cathet Cardiovasc Diagn (1997) 0.78
Antifibrillatory effects of lidocaine and bretylium immediately postcardiopulmonary resuscitation. Am Heart J (1985) 0.78
Stability of omeprazole in an extemporaneously prepared oral liquid. Am J Health Syst Pharm (1997) 0.78
An evaluation of the pharmacokinetics, pharmacodynamics, and dialyzability of verapamil in chronic hemodialysis patients. J Clin Pharmacol (1988) 0.77
Estimation of renal creatinine clearance in patients with unstable serum creatinine concentrations: comparison of multiple methods. Drug Intell Clin Pharm (1985) 0.77
Disposition of intravenous amiodarone in subjects with normal and impaired renal function. J Clin Pharmacol (1996) 0.77
Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function. Clin Pharm (1983) 0.77
A method for determining the pharmacokinetics of endogenous creatinine without exogenous creatinine administration. Biopharm Drug Dispos (1985) 0.77
Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin. Clin Pharm (1986) 0.76
Quantitating functional capacity of mature and immature (nonsegmented) neutrophils. J Infect Dis (1983) 0.76
The effect of amiodarone on the ventricular fibrillation threshold. Pharmacotherapy (1999) 0.76
Effects of different dosages and modes of sodium bicarbonate administration during cardiopulmonary resuscitation. Am J Emerg Med (1992) 0.76
Effects of intravenous fat infusion on neonatal neutrophil and platelet function. JPEN J Parenter Enteral Nutr (1990) 0.75
Bacteraemia after manipulation of the urinary tract. The importance of pre-existing urinary tract disease and compromised host defences. Postgrad Med J (1978) 0.75
Simpler approaches to aminoglycoside monitoring. Am J Hosp Pharm (1994) 0.75
Interference of granulocyte function by the vehicle of miconazole. Antimicrob Agents Chemother (1978) 0.75
Efficacy of class 1C antiarrhythmic agents in patients with inducible ventricular tachycardia refractory to therapy with class 1A antiarrhythmic drugs. J Clin Pharmacol (1993) 0.75
The pharmacokinetic and pharmacodynamic interaction between propafenone and lidocaine. Clin Pharmacol Ther (1993) 0.75
Diltiazem improves resuscitation from experimental ventricular fibrillation in dogs. Crit Care Med (1992) 0.75
Esmolol for the treatment of ventricular tachycardia. DICP (1990) 0.75
Strategy for developing a safe and cost-effective H2-receptor antagonist program. Hosp Formul (1991) 0.75
Granulocyte migration abnormality in patients suffering from seasonal allergic rhinitis: failure of treatment with cimetidine. Int Arch Allergy Appl Immunol (1984) 0.75
Simple and rapid high-performance liquid chromatographic assay for esmolol. J Chromatogr (1991) 0.75
Accuracy of unbound-quinidine concentration determination after ultrafiltration. Clin Pharm (1993) 0.75
A method of determining the in vivo drug release rate constant of sustained-release preparation. Drug Metab Dispos (1995) 0.75
Interaction of epinephrine and beta-blockers. JAMA (1995) 0.75
Stability of famotidine in an extemporaneously prepared oral liquid. Am J Hosp Pharm (1993) 0.75
Pharmacokinetics of intravenous amiodarone in patients with impaired left ventricular function. J Clin Pharmacol (1996) 0.75
Procedure for evaluating nonformulary drug orders. Am J Hosp Pharm (1993) 0.75
Simplified micropore filter assay of neutrophil migration using whole blood. J Infect Dis (1983) 0.75
Evaluation of the need to modify antiarrhythmic therapy because of drug intolerance or inefficacy in patients evaluated by electrophysiology study. Am Heart J (1993) 0.75
Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardia. J Clin Pharmacol (1989) 0.75
Antifibrillatory effect of esmolol alone and in combination with lidocaine. J Cardiovasc Pharmacol (1996) 0.75
Evaluation and comparison of the adverse effects of streptokinase and alteplase. Pharmacotherapy (1992) 0.75
The effect of CPR on plasma diltiazem concentrations in dogs. Ann Emerg Med (1991) 0.75
Epinephrine versus methoxamine in survival postventricular fibrillation and cardiopulmonary resuscitation in dogs. Crit Care Med (1989) 0.75
Analysis of diltiazem and desacetyldiltiazem in plasma using modified high-performance liquid chromatography: improved sensitivity and reproducibility. Pharm Res (1989) 0.75
Lidocaine pharmacokinetics during cardiac arrest and external cardiopulmonary resuscitation. Am Heart J (1981) 0.75
Disopyramide hemodialysis and kinetics in patients requiring long-term hemodialysis. Clin Pharmacol Ther (1981) 0.75
Antifibrillatory and electrophysiologic actions of moricizine alone and in combination with lidocaine: a prospective, randomized trial. Crit Care Med (1993) 0.75
The effect of haloperidol on ventricular fibrillation threshold in pigs. Pharmacol Toxicol (1991) 0.75
Achieving rational therapeutics through consensus-based protocols and follow-up. Hosp Formul (1990) 0.75